Literature DB >> 17229184

Diagnosis and treatment of obsessive-compulsive disorder and related disorders.

B Dell'Osso1, A C Altamura, E Mundo, D Marazziti, E Hollander.   

Abstract

Obsessive-compulsive disorder (OCD) is currently recognised as one of the most common psychiatric disorders as well as one of the most disabling of all medical disorders. Obsessive-compulsive related disorders (OCRDs), often comorbid with OCD, include many distinct psychiatric conditions (i.e. some somatoform disorders, eating disorders, impulse control disorders and some neurological conditions) which have overlapping symptoms and compulsive qualities with OCD. Although effective treatments exist, OCD and related disorders are often underdiagnosed and undertreated. Serotonin reuptake inhibitors (SRIs) and cognitive behavioural therapy (CBT) represent the first-line treatment for OCD and related disorders. However, the time and the doses of the medications used in the treatment of OCD and related disorders differ from those recommended in depressive disorders. In addition, remission is not common for patients with OCD and related disorders in clinical practice, and poor responders as well as refractory cases may benefit from different treatment strategies including integrated treatment, pharmacological augmentation and brain stimulation techniques.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17229184     DOI: 10.1111/j.1742-1241.2006.01167.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  9 in total

Review 1.  Multifunctional pharmacotherapy: what can we learn from study of selective serotonin reuptake inhibitor augmentation of antipsychotics in negative-symptom schizophrenia?

Authors:  Henry Silver; Yael Chertkow; Orly Weinreb; Lena Danovich; Moussa Youdim
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

2.  An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses.

Authors:  A Carlo Altamura; Marta Serati; Alessandra Albano; Riccardo A Paoli; Ira D Glick; Bernardo Dell'Osso
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-02-18       Impact factor: 5.270

3.  Predictive validity of a non-induced mouse model of compulsive-like behavior.

Authors:  D M Greene-Schloesser; E A Van der Zee; D K Sheppard; M R Castillo; K A Gregg; T Burrow; H Foltz; M Slater; A Bult-Ito
Journal:  Behav Brain Res       Date:  2011-02-21       Impact factor: 3.332

Review 4.  Annual Research Review: Transgenic mouse models of childhood-onset psychiatric disorders.

Authors:  Holly R Robertson; Guoping Feng
Journal:  J Child Psychol Psychiatry       Date:  2011-02-10       Impact factor: 8.982

Review 5.  Molecular mechanisms underlying synergistic effects of SSRI-antipsychotic augmentation in treatment of negative symptoms in schizophrenia.

Authors:  Yael Chertkow; Orly Weinreb; Moussa B H Youdim; Henry Silver
Journal:  J Neural Transm (Vienna)       Date:  2009-07-04       Impact factor: 3.575

6.  [Use of medical inpatient services by heavy users: a case of hypochondriasis].

Authors:  Peter Höfer; Michael Ossege; Martin Aigner
Journal:  Neuropsychiatr       Date:  2012-11-06

7.  Regulation of oxytocin receptor gene expression in obsessive-compulsive disorder: a possible role for the microbiota-host epigenetic axis.

Authors:  Claudio D'Addario; Mariangela Pucci; Fabio Bellia; Antonio Girella; Annalaura Sabatucci; Federico Fanti; Matteo Vismara; Beatrice Benatti; Luca Ferrara; Federica Fasciana; Laura Celebre; Caterina Viganò; Luca Elli; Manuel Sergi; Mauro Maccarrone; Valeria Buzzelli; Viviana Trezza; Bernardo Dell'Osso
Journal:  Clin Epigenetics       Date:  2022-03-31       Impact factor: 6.551

8.  Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder.

Authors:  Jonathan T Ting; Guoping Feng
Journal:  Curr Chem Genomics       Date:  2008-01-01

Review 9.  Obsessive-compulsive disorder in children and adolescents: epidemiology, diagnosis and management.

Authors:  Ahsan Nazeer; Finza Latif; Aisha Mondal; Muhammad Waqar Azeem; Donald E Greydanus
Journal:  Transl Pediatr       Date:  2020-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.